TGFB1 and cancer: As a result, extensive research has been conducted to explore the potential role of TGF-β signaling inhibitors as means to overcome cancer treatment resistance (Huang et al., 2012; Sun et al., 2014; Jenkins et al., 2015; Koetz-Ploch et al., 2017; Li et al., 2019a; Wang et al., 2019).